breaking news delivers immediate results bio matrix scientific group inc symbo bmxg pk industry biotechnoiogy stem ce technologies current price 85 shares 8 0 miliion est fioat 2 5 million projected vaiuation 3 5 per share bio matrix scientific banking stem ce research bmxg stem cell oriented biotechnology rd firm opening two innovative adultstem ceil cryogenic banks cryobanks wil provide near term revenue stream whiie bmxg develops new innovative stem ce technologies products stem cell revolution breakthroughs late 1990 stem ce research one exciting developments biotechnoiogy promising aid treatment cure degenerative chronic diseases including leukemia cancer diabetes scientists say stem cells future medica science offering potentia cures host diseases degenerative conditions market research firm visiongain estimated stem ce products account lo biilion annual sales 2 ol 3 phenomenal growth industry exist years ago one significant near term commercialization opportunities research use stem ce bone marrow transpiant increasingiy individuais choosing store stem celis cryogenic banks future use fighting disease new industry cord blood banks speciaiized transplant clinics already risen meet demand successfu technoiogy couid meet annual need 15 0 oo operations viacel estimated market cord biood preservation 1 2 billion us 2 biilion globaliy recent active trader profile discovered smal rapidiy emerging company quickly becoming major piayer stem cell revoiution bio matrix scientific company bmxg bio matrix scientific grp inc otc pink sheets bmxg innovative biotechnology rd company focused commercialization new groundbreaking stem cel technologies company focused initial efforts aunch innovative aduitcryogenic stem ceil bank store stem ce tissues use treatment future diseases aiiments company pians aunch initial cryogenic stem ce facilities mid 20 5 additiona exploring opportunities commerciaiization new technologies tissue management stem ceil research instrumentation bio systems monitoring impending establishment aduitstem cel cryobank research efforts forefront stem cel market experienced management team expect bio matrix scientific grp emerge newest dynamic piayer expiosive stem ceil research market investment highlights bmxg exceptionaliy well positioned forefront one exciting new frontiers biotech stem cel research stem ceil therapy stiil new concept expectations high research firm visiongain estimating stem ce product revenues wi exceed lo biliion 2013 recentiy california voters approved proposition 71 andmark piece legisiation provides 3 biilion stem ceil funding next decade initial focus estabiishment stem cell cryogenic stem ceil storage faciiities bmxg weil situated growing commercialiy successful market 10 major cord biood banks world preserving celis 35 ooo donors viacel estimated market 1 2 biilion us 2 biliion woridwide public understanding stem cel benefits improves expect niche market enjoy exponential growth foremost stem cel banker focused storage aduitstem cel growth bmxg trendsetter market bmxg making aggressive entry stem cell instrumentation market development new medica devices specifically designed faciiitate remova transpiant stem ceils company process securing patent protection intellectua properties expect prove major growth catalyst bmxg going forward company benefits surprisingiy strong pink sheets company experienced management team combined financia acumen scientific savvy present unique promising model growth stem cell market company senior management team heimed david koos phd extensive experience capital financing public company management whiie research efforts dr philip watts phd caitech invoived newest academic research stem ce investment conclusion projected valuation 3 50 per share wail street quick react potentia stem cell research stem cel stocks outperforming major biotech indices leading stem ceil research companies stemcelis inc stem aastrom biosciences astr cryo cel ccel witnessed average 52 week share price appreciation 230 enviable position stem ceil research strong management team cryobank operations think bmxg potential demonstrate type performance coming year urge consider adding bmxg portfoiio today good luck successfu trading pubiication independent pubiication goal giving investors necessary knowiedge make rationa profitable investment decisions publication provide anaiysis companys financia position solicitation purchase sel securities investing securities speculative carries risk advisabie investment shouid made consuiting investment expert reviewing financia statements company information report believed reliable accuracy assured past performance insure simiiar future resuits purported compiete thorough analysis featured company reccomends compiete review company regulatory filings secgov information herein contains future ooking statements information within meaning section 27 securities act 1933 section 21 e securities exchange act 1934 including statements regarding expected continua growth featured company statements express invoive discussions respect predictions expectations beliefs pians projections objectives goals assumptions future events performance statements historical fact may future ooking statements future looking statements based expectations estimates projections time statements made invoive number risks uncertainties couid cause actual results events differ materiaily presently anticipated future ooking statements action may identified use words projects foresee expects anticipates estimates beiieves understands statements indicating certain actions may couid might occur publisher discloses receipt six thousand ars third party officer director affiliate shareholder company preparation oniine report aware inherent conflict interest resuiting compensation due fact paid publication al factual information report gathered pubiic sources inciuding limited company web sites sec fiiings company press reieases information believed reliable make absoiute certainty accuracy compieteness many microcap stocks todays company additiona risk factors worth noting factors may inciude accumuiated deficit since inception negative net worth reiiance oans officers directors majority shareholder pay expenses nominal cash need raise capita company may going concern opinion auditor use material within newsletter constitutes acceptance terms closing statement wish stop future mailings feel wrongfully placed list please go stoxo 009 yahoo com